Comparing Body Composition Assessment Tests in Long-term Hemodialysis Patients

Posted by:

Bross R, Chandramohan G, Kovesdy CP, Oreopoulos A, Noori N, Golden S, Benner D, Kopple JD, Kalantar-Zadeh K.  Am J Kidney Dis. 2010;55(5):885-96 Read more

Dietary Potassium Intake and Mortality in Long-term Hemodialysis Patients.

Posted by:

Noori N, Kalantar-Zadeh K, Kovesdy CP, Murali SB, Bross R, Nissenson AR, Kopple JD. Am J Kidney Dis. 2010;56(2):338-47. Read more

Pharmacokinetics and Safety of Sunitinib Malate in Subjects with Impaired Renal Function

Posted by:

Khosravan R, Toh M, Garrett M, La Frague J, Ni G, Marbury T, Swan S, Lunde J, Bello C.  J Clin Pharmacol. 2010;50(4):472-81. Read more

A Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Multiple Doses of GSK1292263, a Novel GPR119 Agonist

Posted by:

Nunez JD, Lewis EW, Swan SK, Bush MA, Cannon C, McMullen SL, Collins DA, Feldman PL. A Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics… Read more

Association of hemodialysis treatment time and dose with mortality and the role of race and sex.

Posted by:

Miller JE, Kovesdy CP, Nissenson AR, Mehrotra R, Streja E, Van Wyck D, Greenland S, Kalantar-Zadeh K.  Am J Kidney Dis. 2010;55(1):100-12. Read more

Relationship among length of facility ownership, clinical performance, and mortality

Posted by:

Van Wyck D, Robertson J, Nissenson A, Provenzano R, Kogod D. Clin J Am Soc Nephrol. 2010;5(2):248-51. Read more

Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients

Posted by:

Park JC, Kovesdy CP, Duong U, Streja E, Rambod M, Nissenson AR, Sprague SM, Kalantar-Zadeh K.  Hemodial Int. 2010;14(2):182-92. Read more

Vilazodone Pharmacokinetics in Subjects with Mild to Moderate Hepatic Impairment

Posted by:

Longstreth J, Alcorn H, Swan SK, Adams MH, Reed CR. Vilazodone Pharmacokinetics in Subjects with Mild to Moderate Hepatic Impairment. American Psychiatric Association Annual Meeting. New Orleans, LA, May 22-26,… Read more

Vilazodone Pharmacokinetics in Subjects with Mild to Moderate Renal Impairment

Posted by:

Alcorn H, Longsreth J, Swan SK, Adams MH, Reed CR. Vilazodone Pharmacokinetics in Subjects with Mild to Moderate Renal Impairment. American Psychiatric Association Annual Meeting. New Orleans, LA, May 22-26,… Read more

Effect of IMPACT Program on Clinical Indicators of Incident Hemodialysis Patients

Posted by:

Robertson J, Chen G, Goel P, Levine R, Benner D. Effect of IMPACT Program on Clinical Indicators of Incident Hemodialysis Patients. European Renal Association – European Dialysis and Transplant Association…. Read more